SEPTInvestingStart Free

LBRX 424B3: Executive departure

Filed with the SEC on · accession 0001193125-26-391384

LBRX filed a 424B3 (prospectus (offering)) with the SEC on Sep 15, 2026. The final terms of an offering of shares or bonds. The stock moved -4.0% by the first close after the filing.

Summary of the filing

LB Pharmaceuticals appointed Susan G. Kozauer, M.D. as Chief Medical Officer effective September 14, 2026, with compensation including a $515,000 base salary, 40% target bonus, $150,000 sign-on bonus, and 200,000 stock options.

For details, click here →How to read a 424B3 →

Key details

Annual base salary for Chief Medical Officer$515K
Sign-on bonus for Chief Medical Officer$150K
Stock options granted to Chief Medical Officershares 200K
FilerLB Pharmaceuticals Inc
Chief medical officerSusan G. Kozauer

How LBRX stock reacted

Close before

$44.84

Sep 14, 2026

First close after

-4.01%

$43.04

5 trading days

-4.13%

$42.99

Since filing

-8.97%

$40.82

✦ Ask GOAX AI about this filing — what it means for LBRX, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for LBRX?

Click here

Frequently asked questions

What did LBRX file with the SEC on Sep 15, 2026?

LBRX filed a 424B3 (Executive departure). LB Pharmaceuticals appointed Susan G. Kozauer, M.D. as Chief Medical Officer effective September 14, 2026, with compensation including a $515,000 base salary, 40% target bonus, $150,000 sign-on bonus, and 200,000 stock options.

What does a executive departure mean for LBRX stock?

Not always. A planned retirement with a successor is usually calm; a sudden departure “effective immediately”, especially of a CFO or near results, often worries investors.

How do I read a 424B3?

The final terms of an offering of shares or bonds. Look at price, number of shares and the discount to the market price. Large offerings dilute existing shareholders.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 424B3 (prospectus (offering)): The final terms of an offering of shares or bonds.

How did LBRX stock react to this filing?

LBRX closed at $44.84 before the filing and $43.04 on Sep 15, 2026 (-4.01%). Five trading days later: $42.99 (-4.13%).

Other LBRX SEC filings

Get alerts when LBRX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
LBRX overviewLBRX analysisLBRX newsLatest SEC filings